When Professor Liz Lobb was diagnosed with age-related macular degeneration (AMD), her first thought was to resign. The palliative care clinician and researcher wanted to spend the time she feared she had left with her vision doing something other than sitting in front of a computer.
Prof Lobb shared that moment with eye care professionals at a Macular Disease Foundation Australia (MDFA) event in Sydney earlier this week. The evening also brought together the presentation of the inaugural Eye Connect Healthcare Award and MDFA’s first in-person continuing professional development (CPD) session.
Eye Connect Healthcare Award
The Eye Connect Healthcare Award, launched by MDFA in partnership with mivision, attracted more than 100 nominations. It was designed to recognise the extraordinary impact eye care professionals have on the lives of their patients.
Ophthalmologist Dr Stephen Ong was announced the winner on World Sight Day in October. This week he collected his award from the woman who nominated him, his patient, Elizabeth.*
In nominating Dr Ong, Elizabeth recounted an incident where, after a painful reaction to an eye injection, she went to Sydney Eye Hospital’s emergency department on a weekend. Dr Ong reassured her by phone, spoke with nurses on her behalf, and called back several times while she was waiting and into the evening.
Dr Ong shared the recognition with the colleagues who help care for his patients. “When someone trusts you with their sight, a phone call on a Sunday afternoon is never a burden. It’s a privilege,” he said.
MDFA also recognised finalists Emily Luu, a clinical research orthoptist, optometrist David Shanahan, and the team at Bundaberg Eye Clinic.
The evening was also an opportunity for MDFA to provide eye care professionals with a first-hand testimony about the importance of the Eye Connect program to patients.
Prof Lobb took to the microphone to describe how, after being diagnosed with macular disease, her initial panic settled into a steady pattern of injections and monitoring.
She found MDFA’s resources before retiring in 2022 and went from looking for information about her own condition to facilitating an MDFA peer support group, saying the experience has given her the meaning and purpose she needed in retirement.
She said the liveliest part of each meeting was the round-table discussion, where members share practical tips, talk about their experiences with treatment, and support one another through changes such as losing a driver’s licence.
Seeing how members welcome newcomers and respond when someone brings difficult news had given her confidence about her own future, she said.
“I’ve found my tribe and we’ll face it together.”
MDFA CEO Dr Kathy Chapman encouraged clinicians to refer patients to Eye Connect, a free service for people living with AMD or diabetes-related eye conditions. It complements clinical care provided by eye care professionals with information, practical advice, and emotional support between appointments.
In-Person CPD
The evening concluded with the MDFA’s first in-person CPD event, with presentations on three current research projects.
Professor Matthew Simunovic gave an update on the Prima retinal implant, a device being studied for its ability to provide some central vision in people with geographic atrophy due to AMD. Associate Professor Anai Gonzalez-Cordero provided an update on stem cell research on AMD, while Tommy Groeneveld discussed the importance of findings from the Fight Retinal Blindness! Registry in evaluating AMD therapies.
* Full patient name withheld for privacy.



